183 related articles for article (PubMed ID: 37111675)
1.
Balgobind A; Daniels A; Ariatti M; Singh M
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111675
[TBL] [Abstract][Full Text] [Related]
2. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
3. Anti-
Habib S; Daniels A; Ariatti M; Singh M
F1000Res; 2020; 9():770. PubMed ID: 33391729
[No Abstract] [Full Text] [Related]
4. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.
Lee J; Ahn HJ
Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442
[TBL] [Abstract][Full Text] [Related]
5. PEGylated and non-PEGylated siRNA lipoplexes formulated with cholesteryl cytofectins promote efficient luciferase knockdown in HeLa tat luc cells.
Daniels A; Singh M; Ariatti M
Nucleosides Nucleotides Nucleic Acids; 2013; 32(4):206-20. PubMed ID: 24001194
[TBL] [Abstract][Full Text] [Related]
6. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
8. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.
Metwally AA; Blagbrough IS; Mantell JM
Mol Pharm; 2012 Nov; 9(11):3384-95. PubMed ID: 23057412
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
10. Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells.
Hattori Y; Shimizu S; Ozaki KI; Onishi H
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30991703
[TBL] [Abstract][Full Text] [Related]
11. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
[TBL] [Abstract][Full Text] [Related]
12. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
[TBL] [Abstract][Full Text] [Related]
13. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
14. PEGylated galactosylated cationic liposomes for hepatocytic gene delivery.
Naicker K; Ariatti M; Singh M
Colloids Surf B Biointerfaces; 2014 Oct; 122():482-490. PubMed ID: 25096720
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical Factors That Influence the Biocompatibility of Cationic Liposomes and Their Ability to Deliver DNA to the Nuclei of Ovarian Cancer SK-OV-3 Cells.
Sun M; Yuan Y; Lu F; Di Pasqua AJ
Materials (Basel); 2021 Jan; 14(2):. PubMed ID: 33466992
[TBL] [Abstract][Full Text] [Related]
16. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.
Hattori Y; Saito H; Oku T; Ozaki KI
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169
[TBL] [Abstract][Full Text] [Related]
17. siRNA delivery into tumor cells by cationic cholesterol derivative-based nanoparticles and liposomes.
Hattori Y; Hara E; Shingu Y; Minamiguchi D; Nakamura A; Arai S; Ohno H; Kawano K; Fujii N; Yonemochi E
Biol Pharm Bull; 2015; 38(1):30-8. PubMed ID: 25744455
[TBL] [Abstract][Full Text] [Related]
18. Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry.
Hirsch-Lerner D; Barenholz Y
Biochim Biophys Acta; 1999 Nov; 1461(1):47-57. PubMed ID: 10556487
[TBL] [Abstract][Full Text] [Related]
19. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
20. A novel cationic cholesterol derivative, its formulation into liposomes, and the efficient transfection of the transformed human cell lines HepG2 and HeLa.
Kisoon N; Ariatti M; Moodley T
Drug Deliv; 2002; 9(3):161-7. PubMed ID: 12396733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
